CLINICAL_TRIALS
trial_result
· 2016-01-28
Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 [Phase 3]
Summary
A Phase 3 clinical trial evaluating the efficacy and safety of CKD-391 for hyperlipidemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED